P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
about
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4Purinergic signalling in the kidney in health and diseaseMacula densa basolateral ATP release is regulated by luminal [NaCl] and dietary salt intakeExtracellular nucleotides induce migration of renal mesangial cells by upregulating sphingosine kinase-1 expression and activityThe rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1.Transgelin is a marker of repopulating mesangial cells after injury and promotes their proliferation and migration.Purine- and pyrimidine-induced responses and P2Y receptor characterization in the hamster proximal urethra.Contribution of renal purinergic receptors to renal vasoconstriction in angiotensin II-induced hypertensive ratsPurinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertensionActivation of P2Y1 and P2Y2 nucleotide receptors by adenosine 5'-triphosphate analogues augmented nerve-mediated relaxation of human corpus cavernosumEmerging key roles for P2X receptors in the kidneyThe dark side of extracellular ATP in kidney diseasesPurinergic receptors in tubulointerstitial inflammatory cells: a pathophysiological mechanism of salt-sensitive hypertension.P2 receptor regulation of [Ca2+]i in cultured mouse mesangial cells.Cl- secretion in ATP-treated renal epithelial C7-MDCK cells is mediated by activation of P 2Y1 receptors, phospholipase A2 and protein kinase A.Effects of diadenosine polyphosphates on glomerular volume.
P2860
Q24294909-AB511931-DE6F-4B87-BFB3-BF77B37E5882Q26864669-65ACD752-CCC3-499E-BDE8-2F8DEB6E867DQ28241285-C5624B29-156F-4AA7-8D4C-26964AF8DAE8Q28578736-AC660E3C-9339-4B4D-A5AD-10D6C8E16F28Q33200968-E9083FDE-83F7-45F1-BAC6-D092759CE668Q34217138-4E977FB5-A81B-4FB3-B279-ED8B45A66047Q35048645-525081AF-0A9A-49A3-85E3-C280FCC7D5BDQ35057133-D76B465F-58F5-4EAE-92B8-667D47AA3AB7Q36936578-35181724-EBBB-4E96-B46A-179232981F58Q37578289-FF165122-A439-478D-BCC1-65B4ACE8DEBBQ38149864-FC188150-7F7D-4C9F-B941-5C87B1EF0478Q38276349-10E36035-3286-4FF4-A4CE-9BF3321CFB38Q38356338-5AA0EDC4-C803-4007-A3F3-A3E635F94001Q40184921-BBEC7CC2-7FEC-415F-841A-8326D7AB1C90Q40383662-1A4407DF-CB7F-4989-BC3C-0E1CF0C8D63EQ43261508-EB423A90-B402-4B23-B8C5-193A0CA446C3
P2860
P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
P2 receptor antagonist PPADS i ...... liferative glomerulonephritis.
@ast
P2 receptor antagonist PPADS i ...... liferative glomerulonephritis.
@en
type
label
P2 receptor antagonist PPADS i ...... liferative glomerulonephritis.
@ast
P2 receptor antagonist PPADS i ...... liferative glomerulonephritis.
@en
prefLabel
P2 receptor antagonist PPADS i ...... liferative glomerulonephritis.
@ast
P2 receptor antagonist PPADS i ...... liferative glomerulonephritis.
@en
P2093
P1433
P1476
P2 receptor antagonist PPADS i ...... liferative glomerulonephritis.
@en
P2093
Christian Hugo
Christoph Daniel
Eckhard Schulze-Lohoff
Günter Lambrecht
Hans G Bäumert
Sylvia Rost
P304
P356
10.1046/J.1523-1755.2002.00621.X
P407
P577
2002-11-01T00:00:00Z
P5875
P6179
1025176073